HAE Financial Facts
Net income: 0.39Selling, general and administrative: 71.12M
See Full Income Statement
Total stockholders' equity: 749.11M
Cash and cash equivalents: 138.87M
See Full Balance Sheet
Haemonetics Corp. (HAE) Earnings
|
Expand Research on HAE
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +7.4% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/7/26  |
Q426 | N/A | $1.27 | N/A | N/A | $337.3M | = | N/A | N/A | ||
| 2/5/26 | Q326 | $1.31 | $1.25 | +$0.06 | $338.97M | $331.91M | = |  | | Details | |
| 11/6/25 | Q226 | $1.27 | $1.11 | +$0.16 | $327M | $311.46M | = | | | Details | |
| 8/7/25 | Q126 | $1.10 | $1.01 | +$0.09 | $321.39M | $302.62M | = | | | Details | |
| 5/8/25 | Q425 | $1.24 | $1.22 | +$0.02 | $331M | $330.66M | = | | | Details | |
| 2/6/25 | Q325 | $1.19 | $1.17 | +$0.02 | $349M | $352.98M | = | | | Details | |
| 11/7/24 | Q225 | $1.12 | $1.07 | +$0.05 | $346M | $342.58M | = | | | Details | |
| 8/8/24 | Q125 | $1.02 | $1.01 | +$0.01 | $336.17M | $335.05M | = | | | Details |
